Recently, substantial progress has been made in understanding the role of immune cell infiltration in colon cancer, which has led to the development of the Immunoscore in stage I–III colon cancer, based on the quantification of CD3+ and CD8+ lymphocytes in the tumor and its invasive margin [9]. This evidence concerns the gene CD8A and colonic neoplasm.